Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 15.95%102.35B | 13.79%96.43B | 12.04%90.23B | 13.87%350.02B | 11.77%96.47B | 15.09%88.27B | 13.59%84.74B | 15.41%80.54B | 8.68%307.39B | 13.49%86.31B |
| Operating revenue | 15.95%102.35B | 13.79%96.43B | 12.04%90.23B | 13.87%350.02B | 11.77%96.47B | 15.09%88.27B | 13.59%84.74B | 15.41%80.54B | 8.68%307.39B | 13.49%86.31B |
| Cost of revenue | 13.42%41.37B | 9.95%39.04B | 7.86%36.36B | 9.73%146.31B | 8.09%40.61B | 9.77%36.47B | 11.25%35.51B | 10.13%33.71B | 5.65%133.33B | 6.32%37.58B |
| Gross profit | 17.73%60.98B | 16.56%57.39B | 15.05%53.87B | 17.03%203.71B | 14.61%55.86B | 19.17%51.79B | 15.34%49.24B | 19.53%46.83B | 11.13%174.06B | 19.72%48.74B |
| Operating expense | 27.83%29.75B | 19.75%26.12B | 8.95%23.27B | 1.73%91.32B | -0.62%24.88B | 5.21%23.27B | 4.60%21.81B | -1.86%21.36B | 9.75%89.77B | 11.05%25.04B |
| Selling and administrative expenses | 34.84%14.6B | 23.72%12.31B | 2.74%9.71B | -5.29%42B | -8.95%11.77B | -0.34%10.83B | -3.04%9.95B | -8.16%9.45B | 4.85%44.34B | 5.26%12.93B |
| -Selling and marketing expense | -0.30%7.21B | 4.55%7.1B | -3.95%6.17B | -0.39%27.81B | -4.61%7.36B | 4.98%7.23B | 0.16%6.79B | -1.64%6.43B | 5.08%27.92B | 7.46%7.72B |
| -General and administrative expense | 105.42%7.39B | 64.95%5.21B | 16.95%3.54B | -13.62%14.19B | -15.39%4.41B | -9.55%3.6B | -9.28%3.16B | -19.50%3.03B | 4.46%16.43B | 2.16%5.21B |
| Research and development costs | 21.72%15.15B | 16.42%13.81B | 13.89%13.56B | 8.58%49.33B | 8.28%13.12B | 10.56%12.45B | 12.01%11.86B | 3.79%11.9B | 15.01%45.43B | 17.98%12.11B |
| Operating profit | 9.49%31.23B | 14.02%31.27B | 20.16%30.61B | 33.33%112.39B | 30.70%30.97B | 33.63%28.52B | 25.58%27.43B | 46.26%25.47B | 12.63%84.29B | 30.49%23.7B |
| Net non-operating interest income (expenses) | -21.53%933M | -22.87%789M | 0.00%967M | 18.47%4.21B | -0.58%1.04B | 25.16%1.19B | 20.49%1.02B | 34.87%967M | 95.76%3.56B | 82.95%1.04B |
| Non-operating interest income | -13.44%1.08B | -3.67%1.05B | -5.66%1B | 15.96%4.48B | -1.98%1.09B | 16.60%1.24B | 22.20%1.09B | 33.12%1.06B | 77.78%3.87B | 68.44%1.11B |
| Non-operating interest expense | 164.81%143M | 289.55%261M | -63.83%34M | -12.99%268M | -23.19%53M | -53.45%54M | 55.81%67M | 17.50%94M | -13.73%308M | -23.33%69M |
| Other net income (expenses) | 492.48%11.83B | 308.81%1.87B | 444.56%10.22B | 250.54%3.21B | 172.39%236M | 282.12%2B | -14.41%-897M | 2,469.86%1.88B | 59.99%-2.13B | 79.39%-326M |
| Gain on sale of security | 434.58%10.71B | 215.46%1.38B | 538.63%9.85B | 209.75%2.26B | -500.00%-88M | 269.83%2B | -54.05%-1.2B | 1,324.60%1.54B | 66.61%-2.06B | 101.19%22M |
| Special income (charges) | 71.96%-30M | 1,209.38%419M | 15.38%-22M | 70.06%-188M | 66.02%-87M | 50.23%-107M | 130.19%32M | 49.02%-26M | -86.35%-628M | -725.81%-256M |
| -Less:Write off | -71.96%30M | -1,209.38%-419M | -15.38%22M | -70.06%188M | -66.02%87M | -50.23%107M | -130.19%-32M | -49.02%26M | 86.35%628M | 725.81%256M |
| Other non-operating income (expenses) | 1,054.55%1.14B | -73.13%72M | 6.96%384M | 104.50%1.14B | 546.74%411M | -66.89%99M | 170.71%268M | 43.60%359M | -52.84%556M | -130.98%-92M |
| Income before tax | 38.73%43.99B | 23.16%33.93B | 47.59%41.79B | 39.78%119.82B | 32.08%32.24B | 49.58%31.71B | 25.79%27.55B | 55.53%28.32B | 20.17%85.72B | 42.37%24.41B |
| Income tax | 66.66%9.01B | 45.91%5.74B | 55.79%7.25B | 65.22%19.7B | 53.21%5.71B | 258.42%5.41B | 11.23%3.93B | 47.53%4.65B | 4.98%11.92B | 5.73%3.73B |
| Earnings from equity interest net of tax | ||||||||||
| Net income | 32.99%34.98B | 19.38%28.2B | 45.97%34.54B | 35.67%100.12B | 28.27%26.54B | 33.58%26.3B | 28.59%23.62B | 57.21%23.66B | 23.05%73.8B | 51.84%20.69B |
| Net income continuous operations | 32.99%34.98B | 19.38%28.2B | 45.97%34.54B | 35.67%100.12B | 28.27%26.54B | 33.58%26.3B | 28.59%23.62B | 57.21%23.66B | 23.05%73.8B | 51.84%20.69B |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 32.99%34.98B | 19.38%28.2B | 45.97%34.54B | 35.67%100.12B | 28.27%26.54B | 33.58%26.3B | 28.59%23.62B | 57.21%23.66B | 23.05%73.8B | 51.84%20.69B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 32.99%34.98B | 19.38%28.2B | 45.97%34.54B | 35.67%100.12B | 28.27%26.54B | 33.58%26.3B | 28.59%23.62B | 57.21%23.66B | 23.05%73.8B | 51.84%20.69B |
| Diluted earnings per share | 35.05%0.352 | 21.99%0.2838 | 48.69%0.3459 | 39.21%0.9902 | 30.72%0.2643 | 37.18%0.2606 | 31.72%0.2326 | 61.86%0.2326 | 27.23%0.7113 | 56.60%0.2022 |
| Basic earnings per share | 35.38%0.3495 | 22.22%0.2813 | 48.68%0.3422 | 38.62%0.9792 | 31.10%0.2618 | 36.77%0.2582 | 31.25%0.2302 | 61.54%0.2302 | 27.19%0.7064 | 56.19%0.1997 |
| Dividend per share | -0.66%0.0245 | 2.23%0.025 | 0.0231 | 0.0723 | 0.0232 | 0.0247 | 0.0244 | |||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.